-
CARB-X Commits $48M for Antibiotic Resistance R&D
A public-private partnership is spending $48 million in grants to biotechnology companies for research on treatments and diagnostics to counter antibiotic resistance, with half of that amount distributed immediately.
-
Univ. Spin-Off Designing Heart Disease Screening App
A spin-off enterprise from Massachusetts Institute of Technology is creating a system using a smartphone camera to detect heart rhythm problems that lead to a stroke.
-
FDA Approves Multiple Sclerosis Therapy
The Food and Drug Administration approved a synthetic targeted antibody to treat multiple sclerosis in people with relapsing or steadily worsening forms of the disease.
-
Climate-Resistant Oilseed Crop Plant Developed
An academic-industry team developed a new crop plant variety that produces cooking oil like rapeseed or canola, but in a warmer and dryer climate.
-
Univ. of California to Gain European Crispr-Cas9 Patent
A patent dispute among top research universities took another turn, as the European Patent Office announced its intention to grant a patent to University of California for its genome editing techniques.
-
Diet Enhancing Gut Microbes Shown to Slow Type 1 Diabetes
A diet that produces certain short-chain fatty acids in the gut is shown in lab mice to support the immune system and slow the onset of type 1 diabetes.
-
Trials, Registry Planned for Wound Care Device
A company making products for healing wounds is studying the ways one of its dressings is used in the field, to better understand the product’s role in wound care.
-
T-Cell Therapy Trial Begins for Autoimmune Diseases
A biotechnology company began testing on humans an experimental drug to increase healthy T-cells in the immune system for people with autoimmune disorders.
-
Challenge Seeks GI Tract Drug Delivery in Animals
A new challenge offered through InnoCentive is aiming for solutions to protect biological drugs delivered into the gastrointestinal, or GI, tract of animals.
-
Genetic Techniques Speed Brain, Muscle Cell Production
A new technology targets the expression of genes in stem cells to produce specific brain and muscle cells on demand and in a few days, a fraction of the time now required.